IBT
AKRO

International Biotechnology Trust’s Akero Therapeutics AKRO Stock Holding History

International Biotechnology Trust’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$935K Sell
18,489
-60,000
-76% -$2.79M 0.32% 53
2023
Q2 		$3.66M Buy
+78,489
New +$3.6M 1.11% 28

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

International Biotechnology Trust's AKRO Position: Q3 2023 in Review

International Biotechnology Trust reduced its Akero Therapeutics (AKRO) stake by 76% in Q3 2023, selling an estimated $2.79M and leaving 18,489 shares worth $935K. The position accounts for 0.32% of the portfolio, ranked #53.

International Biotechnology Trust first reported a position in AKRO in Q2 2023 and has held it in 2 quarters since. The position peaked at $3.66M in Q2 2023. 181 funds tracked by Wall St. Rank hold AKRO as of Q3 2023.

  • International Biotechnology Trust held 18,489 shares of Akero Therapeutics worth $935K as of Q3 2023.
  • International Biotechnology Trust sold 60,000 Akero Therapeutics shares in Q3 2023, an estimated $2.79M.
  • Akero Therapeutics made up 0.32% of International Biotechnology Trust's portfolio in Q3 2023, its #53 holding.
  • International Biotechnology Trust first reported a position in Akero Therapeutics in Q2 2023 and has held it in 2 quarters since.
  • International Biotechnology Trust's Akero Therapeutics position peaked at $3.66M in Q2 2023.
  • 181 funds tracked by Wall St. Rank held Akero Therapeutics as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.